SCD and cancer: We further examined the proliferative effect of SCD1 on cancer cells using CAY10566, an inhibitor of SCD1, and siRNA against SCD1. Consistent with the previous reports, inhibition of SCD1 decreased cancer cell proliferation [29, 30], but did not affect normal cell viability, suggesting cancer-specific cytotoxicity of SCD1 suppression.